Ultragenyx Pharmaceutical Inc.
RARE
$39.64
$0.300.76%
RARE market cap represents
0.05%
of the sector.
Valuation
RARE
Low
RARE
Sector Average
High
Market Cap
3.64B
< 3.64B
> 16.25B
Enterprise Value
3.81B
< 3.81B
> 18.37B
Price/Earnings (TTM)
-6.20
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
-23.87%
< -50.00%
> -10.00%
Price/Earnings To Growth (TTM)
--
0.00
12.21
Price/Sales (TTM)
6.72
< 0.000
> 440.00
Price/Book (Q)
14.25
< 0.00
> 20.00
Enterprise Value/Revenue (TTM)
6.80
< 0.00
> 210.00
Enterprise Value/EBITDA (TTM)
-7.62
< -10.00
> 0.00
Enterprise Value/EBIT (TTM)
-7.11
< -10.00
> 10.00
Dividends and Shares
RARE
Low
RARE
Sector Average
High
Shares Outstanding
95.68M
< 50.00M
> 240.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.67%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
RARE
Low
RARE
Sector Average
High
Beta
1.01
< -10.00
5.35
1-Month Total Return
-9.81%
< -20.00%
> 0.00%
3-Month Total Return
-13.35%
< -20.00%
> 0.00%
6-Month Total Return
-33.73%
< -40.00%
> 10.00%
Year to Date Total Return
-4.40%
< -20.00%
> 0.00%
1-Year Total Return
-16.95%
< -20.00%
> 10.00%
2-Year Total Return
-3.41%
< -10.00%
> 440.00%
3-Year Total Return
-38.23%
< -40.00%
> 0.00%
5-Year Total Return
16.39%
< 10.00%
> 220.00%
Profitability
RARE
Low
RARE
Sector Average
High
Operating Margin (TTM)
-95.67%
< -13,030.00%
> -90.00%
Profit Margin (TTM)
-101.59%
< -12,560.00%
> -100.00%
Management Effectiveness
RARE
Low
RARE
Sector Average
High
Return on Assets (TTM)
-22.37%
< -50.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
824.40%
Income Statement
RARE
Low
RARE
Sector Average
High
Revenue (TTM)
560.23M
< 560.00M
> 12.30B
Total Revenue (TTM)
560.23M
< 560.00M
> 12.49B
Total Revenue Growth (Q YOY)
29.42%
< 20.00%
> 1,440.00%
Revenue Per Share (TTM)
5.86
< 0.00
> 200.00
Gross Profit (TTM)
-554.35M
< -560.00M
> 3.74B
EBITDA (TTM)
-500.43M
< -510.00M
> 1.10B
EBIT (TTM)
-535.97M
< -540.00M
> 730.00M
Net Income (TTM)
-569.18M
< -570.00M
> 270.00M
Net Income Avl. to Common (TTM)
-569.18M
< -570.00M
> 270.00M
Earnings Growth (Q YOY)
-8.28%
< -290.00%
> 0.00%
EPS Diluted (TTM)
-6.34
< -5,460.00
> 0.00
EPS Diluted Growth (Q YOY)
8.20%
< -20.00%
> 10.00%
Balance Sheet
RARE
Low
RARE
Sector Average
High
Cash and Short-Term Inv. (Q)
610.03M
< 340.00M
> 1.38B
Cash Per Share (Q)
6.38
0.00
> 200.00
Total Current Assets (Q)
817.12M
< 810.00M
> 3.46B
Total Assets (Q)
1.50B
< 1.50B
> 9.79B
Total Current Liabilities (Q)
344.15M
< 340.00M
> 2.57B
Total Debt (Q)
910.01M
< 780.00M
> 3.15B
Total Liabilities (Q)
1.24B
< 1.24B
> 6.15B
Total Common Equity (Q)
255.30M
< 250.00M
> 3.55B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
262.30M
< 260.00M
> 3.65B
Current Ratio (Q)
2.374
0.009
> 20.000
Book Value Per Share (Q)
2.76
< 0.00
> 2,170.00
Cash Flow
RARE
Low
RARE
Sector Average
High
Cash from Operations (TTM)
-414.19M
< -420.00M
> 730.00M
Cash from Investing (TTM)
-17.77M
< -590.00M
> -10.00M
Cash from Financing (TTM)
399.24M
< -190.00M
> 400.00M
Net Change in Cash (TTM)
-35.24M
< -40.00M
> 0.00
Levered Free Cash Flow (TTM)
-207.49M
< -210.00M
> 540.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
